News

Q2 2025 Management View CEO Mitchell Steiner emphasized Veru’s focus on its obesity program, highlighting the positive Phase 2b clinical trial results for enobosarm. This drug, when combined with ...
Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...
Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...
The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...
We expected miracles—what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Against increasing use of weight loss jabs, Weight Watchers has filed for bankruptcy. Writer Daisy Buchanan reflects on her ...
Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision to declare the end of the shortage of Novo Nordisk’s semaglutide, Judge ...
Ozempic is hailed as a miracle drug by some people using it to lose weight, however, it isn't suitable for everyone and can ...
Ozempic has posed a lot of side effects for its users, but now dentists are warning about another major symptom that could ...
In the bankruptcy filing, WeightWatchers' parent company, WW International Inc., said nearly three-quarters of its creditors ...